SOLTFOTCHealthcare · Biotechnology

Nxera Pharma Co., Ltd.

$7.31-7.88%($-0.63)

TickerSpark Score

61/100

Mixed

Valuation

Profitability

Growth

Health

100

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SOLTF research report →

52-Week Range100% of range

Low $4.90

Current $7.31

High $7.31

Companysoseiheptares.com

Nxera Pharma Co. , Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom.

CEO: Christopher Cargill
IPO: 2013
Employees: 387
HQ: Tokyo, JP

Price Chart

+23.69% · this period

Valuation

Market Cap: $670.92M
P/E: -10.22
P/S: 3.02
P/B: 1.60
EV/EBITDA: 69.27
Div Yield: 0.00%

Profitability

Gross Margin: 77.50%
Op Margin: -6.59%
Net Margin: -29.15%
ROE: -15.58%
ROIC: -1.80%

Growth & Income

Revenue: $29.64B · 2.79%
Net Income: $-12,540,934,000 · -159.22%
EPS: $-139.60 · -158.76%
Op Income: $-8,281,220,000
FCF YoY: 66.30%

Performance & Tape

52W High: $7.31
52W Low: $4.90
50D MA: $5.91
200D MA: $5.85
Beta: 0.17
Avg Volume: 1.15K

Get TickerSpark's AI analysis on SOLTF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime